RU2018122224A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2018122224A3 RU2018122224A3 RU2018122224A RU2018122224A RU2018122224A3 RU 2018122224 A3 RU2018122224 A3 RU 2018122224A3 RU 2018122224 A RU2018122224 A RU 2018122224A RU 2018122224 A RU2018122224 A RU 2018122224A RU 2018122224 A3 RU2018122224 A3 RU 2018122224A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015-227468 | 2015-11-20 | ||
| JP2015227468 | 2015-11-20 | ||
| JP2016-111944 | 2016-06-03 | ||
| JP2016111944 | 2016-06-03 | ||
| PCT/JP2016/084227 WO2017086430A1 (ja) | 2015-11-20 | 2016-11-18 | Ｎａｓｈの治療又は予防のための医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2018122224A RU2018122224A (ru) | 2019-12-25 |
| RU2018122224A3 true RU2018122224A3 (ru) | 2020-03-27 |
Family
ID=58717447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018122224A RU2018122224A (ru) | 2015-11-20 | 2016-11-18 | Фармацевтическая композиция для лечения или предупреждения nash |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20180360803A1 (ru) |
| EP (1) | EP3378491A4 (ru) |
| JP (1) | JPWO2017086430A1 (ru) |
| KR (1) | KR20180082564A (ru) |
| CN (1) | CN108348610A (ru) |
| AU (1) | AU2016355863A1 (ru) |
| BR (1) | BR112018010107A8 (ru) |
| CA (1) | CA3005811A1 (ru) |
| MX (1) | MX2018006225A (ru) |
| RU (1) | RU2018122224A (ru) |
| WO (1) | WO2017086430A1 (ru) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX370408B (es) * | 2014-06-27 | 2019-12-11 | Ube Industries | Sal de compuesto heterociclico sustituido con halogeno. |
| WO2019041340A1 (en) * | 2017-09-04 | 2019-03-07 | Eli Lilly And Company | LYSOPHOSPHATIDE ACID RECEPTOR 1 RECEPTOR INHIBITORS (LPAR1) |
| CA3158743A1 (en) | 2019-11-15 | 2021-05-20 | Gilead Sciences, Inc. | Triazole carbamate pyridyl sulfonamides as lpa receptor antagonists and uses thereof |
| CA3185689A1 (en) | 2020-06-03 | 2021-12-09 | Gilead Sciences, Inc. | Lpa receptor antagonists and uses thereof |
| TWI843503B (zh) | 2020-06-03 | 2024-05-21 | 美商基利科學股份有限公司 | Lpa受體拮抗劑及其用途 |
| CA3218917A1 (en) | 2021-05-11 | 2022-11-17 | Gilead Sciences, Inc. | Lpa receptor antagonists and uses thereof |
| AU2022405082B2 (en) | 2021-12-08 | 2025-09-25 | Gilead Sciences, Inc. | Lpa receptor antagonists and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2466121B (en) * | 2008-12-15 | 2010-12-08 | Amira Pharmaceuticals Inc | Antagonists of lysophosphatidic acid receptors |
| PT2648726T (pt) * | 2010-12-07 | 2018-06-25 | Amira Pharmaceuticals Inc | Antagonista de lpa1 policíclico e utilizações do mesmo |
| WO2012138648A1 (en) * | 2011-04-06 | 2012-10-11 | Irm Llc | Compositions and methods for modulating lpa receptors |
| EP2940013B1 (en) * | 2012-12-28 | 2018-02-21 | Ube Industries, Ltd. | Halogen-substituted heterocyclic compound |
| SG11201507459YA (en) * | 2013-03-15 | 2015-10-29 | Epigen Biosciences Inc | Heterocyclic compounds useful in the treatment of disease |
| MX370408B (es) * | 2014-06-27 | 2019-12-11 | Ube Industries | Sal de compuesto heterociclico sustituido con halogeno. |
-
2016
- 2016-11-18 CA CA3005811A patent/CA3005811A1/en not_active Abandoned
- 2016-11-18 US US15/777,548 patent/US20180360803A1/en not_active Abandoned
- 2016-11-18 BR BR112018010107A patent/BR112018010107A8/pt not_active Application Discontinuation
- 2016-11-18 AU AU2016355863A patent/AU2016355863A1/en not_active Abandoned
- 2016-11-18 CN CN201680067778.1A patent/CN108348610A/zh active Pending
- 2016-11-18 JP JP2017551943A patent/JPWO2017086430A1/ja not_active Withdrawn
- 2016-11-18 RU RU2018122224A patent/RU2018122224A/ru not_active Application Discontinuation
- 2016-11-18 MX MX2018006225A patent/MX2018006225A/es unknown
- 2016-11-18 KR KR1020187016782A patent/KR20180082564A/ko not_active Withdrawn
- 2016-11-18 WO PCT/JP2016/084227 patent/WO2017086430A1/ja not_active Ceased
- 2016-11-18 EP EP16866430.8A patent/EP3378491A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| BR112018010107A8 (pt) | 2023-05-09 |
| RU2018122224A (ru) | 2019-12-25 |
| CA3005811A1 (en) | 2017-05-26 |
| KR20180082564A (ko) | 2018-07-18 |
| WO2017086430A1 (ja) | 2017-05-26 |
| JPWO2017086430A1 (ja) | 2018-09-06 |
| AU2016355863A1 (en) | 2018-07-05 |
| EP3378491A1 (en) | 2018-09-26 |
| CN108348610A (zh) | 2018-07-31 |
| EP3378491A4 (en) | 2019-07-17 |
| MX2018006225A (es) | 2018-11-09 |
| US20180360803A1 (en) | 2018-12-20 |
| BR112018010107A2 (pt) | 2018-11-21 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20210602 |